Society of Hematologic Oncology
LightNews LightNews
banner
societyofhemonc.bsky.social
Society of Hematologic Oncology
@societyofhemonc.bsky.social
47 followers 22 following 280 posts
Get the latest news on sohoinsider.com, the official news source from SOHO.

Register for our community oncology series at https://soho.click/community-oncology-series

Become a SOHO member for free at soho.click/join.
Posts Replies Media Videos
societyofhemonc.bsky.social
Check out our roundtable discussion with @lymphomadoc.bsky.social on CELLMoDS in FL & large cell lymphoma.

youtu.be/OXKSVyH96iY
What are the therapeutic combinations in large cell lymphoma?
YouTube video by The Society of Hematologic Oncology
youtu.be
February 8, 2026 at 1:41 AM
societyofhemonc.bsky.social
Orca-T immunotherapy improves QOL, resource use over conventional allogeneic HSCT

sohoinsider.com/leukemia/soh...
Orca-T Immunotherapy: Phase 3 Results from Tandem 2026 - SOHO Insider
Phase 3 data on Orca-T immunotherapy from the 2026 Tandem Meetings. Learn how this cell therapy improves leukemia transplant outcomes.
sohoinsider.com
February 7, 2026 at 2:37 AM
societyofhemonc.bsky.social
Smoldering MM trends data show increased incidence in certain patient populations
sohoinsider.com/news/smolder...
Smoldering MM Incidence Rises 50% in the US
New 2026 data shows a 50% increase in Smoldering Multiple Myeloma (SMM) incidence from 2012 to 2022 according to SEER data.
sohoinsider.com
February 4, 2026 at 4:49 AM
societyofhemonc.bsky.social
Registration is open for 4th SOHO Israel Annual Meeting

sohoinsider.com/news/registr...
Registration is open for 4th SOHO Israel Annual Meeting
Register now for the 4th SOHO Israel annual meeting in conjunction with the 10th international Davidoff conference.
sohoinsider.com
February 2, 2026 at 12:43 PM
societyofhemonc.bsky.social
"The goal of the next generation of therapies is ... about trying to delay the natural history of the disease," Douglas Tremblay says about ET in the latest SOHO Insider podcast episode with host Dr. Andrew Kuykendall. #MedSky

sohoinsider.com/myeloprolife...
January 31, 2026 at 7:34 PM
societyofhemonc.bsky.social
FDA approves daratumumab, hyaluronidase-fihj, VRd in newly diagnosed myeloma

sohoinsider.com/news/fda-app...
FDA approves daratumumab-faspro, VRd in MM- SOHO Insider
The US FDA has approved daratumumab-faspro in combination with VRd for adults with newly diagnosed multiple myeloma.
sohoinsider.com
January 30, 2026 at 4:46 AM
societyofhemonc.bsky.social
Study shows PRO data are important component of treatment efficacy, tolerability assessment

sohoinsider.com/news/pro-dat...
PRO Data k ey to treatment efficacy and tolerability - SOHO Insider
POLARIX study data shows patient-reported outcomes PROs are essential for assessment of treatment efficacy and adverse event reporting.
sohoinsider.com
January 29, 2026 at 3:28 AM
societyofhemonc.bsky.social
"CAR-T cell therapy should be defined by biological eligibility and not by geography." 🧬

Watch Dr. Manali Kamdar discuss expanding CAR-T access in the community setting in our Community Oncology Brown Bag series.

sohoinsider.com/news/communi...

Register at soho.click/community-on...
January 28, 2026 at 6:16 AM
societyofhemonc.bsky.social
SOHO Asia debuts in Taipei with 400 attendees from across Asia-Pacific

sohoinsider.com/ambassador-p...
SOHO Asia debuts in Taipei with attendees from across Asia-Pacific
SOHO Asia debuts in Taipei with 400 attendees from across Asia-Pacific and researchers from top institutions, including MD Anderson.
sohoinsider.com
January 28, 2026 at 4:15 AM
societyofhemonc.bsky.social
FDA grants zavabresib orphan drug designation in myelofibrosis

sohoinsider.com/news/zavabre...
zavabresib receives FDA ODD for myelofibrosis
zavabresib (OPN-2853) receives FDA Orphan Drug Designation for myelofibrosis following data from the Phase 1 PROMise trial.
sohoinsider.com
January 27, 2026 at 9:29 AM
societyofhemonc.bsky.social
1st SOHO Asia hopes to empower hematology community across Asia
sohoinsider.com/news/1st-soh...
SOHO Asia holds 1st meeting
SOHO Asia held its first meeting in Taipei, Taiwan in January 2026. The event invited hematologist from across Asia.
sohoinsider.com
January 24, 2026 at 8:40 AM
societyofhemonc.bsky.social
FDA grants breakthrough designation to CAR-T therapy sofi-cel

sohoinsider.com/leukemia/fda...
FDA grants breakthrough designation to CAR-T therapy sofi-cel
Sofi-cel, an allogeneic, off-the-shelf, CD7-targeted CAR-T cell therapy, has previously received regenerative medicine advanced therapy, fast track, orphan drug, and rare pediatric disease designation...
sohoinsider.com
January 22, 2026 at 6:15 AM
societyofhemonc.bsky.social
Dr. Kelly Bolton on ivosidenib in IDH1-mutated CCUS

sohoinsider.com/leukemia/dr-...
January 21, 2026 at 10:04 AM
societyofhemonc.bsky.social
How to approach 1L patients in follicular lymphoma? Watch our roundtable discussion on the topic.

sohoinsider.com/lymphoma/dr-...
January 18, 2026 at 12:42 AM
societyofhemonc.bsky.social
Dr. Manali Kamdar to give free virtual CAR-T talk at 4:30 pm CT on Jan. 20
Registration details:

sohoinsider.com/cellular-the...
Dr. Manali Kamdar to give free virtual CAR-T talk
Dr. Manali Kamdar to give free virtual CAR-T talk at 4:30 pm CT on Jan. 20. This resource will be available after the session
sohoinsider.com
January 17, 2026 at 7:40 PM
societyofhemonc.bsky.social
Earlier lines of cilta-cel linked to better immune fitness in myeloma

sohoinsider.com/news/dr-pare...
January 16, 2026 at 4:42 AM
societyofhemonc.bsky.social
‘A stretch of normal life’ as myeloma patients enter uncharted era
sohoinsider.com/news/treatme...
Treatment successes inspire some to declare myeloma curable
The treatment successes of patients, including those who received the CAR-T cell cilta-cel, have prompted discussions of cure in myeloma.
sohoinsider.com
January 14, 2026 at 5:17 AM
societyofhemonc.bsky.social
Dr. Gwen Nichols, of @bloodcancerunited.bsky.social, discusses financial toxicity in #bloodcancer care.

sohoinsider.com/leukemia/dr-...
January 13, 2026 at 6:35 AM
societyofhemonc.bsky.social
Registration is now open for #SOHO2026. Catch those early bird rates before time is up. Register at soho.click/2026. SOHO members get a 40% discount. Join SOHO for free at soho.click/join. #SOHO26
January 12, 2026 at 10:59 PM
societyofhemonc.bsky.social
On this sohoinsider.com podcast, Dr. Tom Martin
interviews 1st US patient w/ #myeloma who was treated with cilta-cel (then LCAR-B38M) in China. Stay tuned for the full feature 📰 next week.

sohoinsider.com/cellular-the...
January 10, 2026 at 3:11 AM
societyofhemonc.bsky.social
Watch our video interview on DOCK1 inhibition in TP53-mutant clonal hematopoiesis

www.youtube.com/watch?v=5OY4...
Yang Feng, PhD, discusses #ASH25 abstract on DOCK1 inhibition in TP53-mutant clonal hematopoiesis
YouTube video by The Society of Hematologic Oncology
www.youtube.com
January 8, 2026 at 4:43 AM
societyofhemonc.bsky.social
Triplet therapy shows efficacy, tolerability, and transplant potential in #BPDCN

sohoinsider.com/meetings-con...
Tagraxofusp, azacitidine, and venetoclax triplet shows efficacy
Tagraxofusp, azacitidine, and venetoclax triplet shows efficacy in phase 2 trial updates at ASH in Orlando, Florida.
sohoinsider.com
January 8, 2026 at 3:43 AM
societyofhemonc.bsky.social
Dr. Avalos highlights #ASH25 takeaways, the future of blood cancer

sohoinsider.com/leukemia/acu...
Dr. Avalos highlights ASH 2025 takeaways
Dr. Belinda Avalos the biggest highlights from ASH 2025 and the future of blood cancer. The meeting was held in December 2025 in Orlando.
sohoinsider.com
January 7, 2026 at 2:05 AM
societyofhemonc.bsky.social
“You can think of the catalytic activity somewhat like having a drug that acts like a serial killer...it can degrade each target sequentially, achieving a very high potency," Dr.Chen explains how one Opna degrader molecule hits targets inside #myeloma cells #ASH25

sohoinsider.com/meetings-con...
January 5, 2026 at 9:54 PM
societyofhemonc.bsky.social
“Patients who had failed to respond properly to ruxolitinib are now seeing their spleens completely normalize.”

Watch Dr. Adam Mead explain why the PROMise trial’s early results could change the outlook in myelofibrosis. #ASH25

sohoinsider.com/myeloprolife...
January 3, 2026 at 4:26 PM